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The amyloid precursor protein (APP) was discovered in the 1980s as the precursor
protein of the amyloid A4 peptide. The amyloid A4 peptide, also known as A-beta
(Aβ), is the main constituent of senile plaques implicated in Alzheimer’s disease (AD).
In association with the amyloid deposits, increasing impairments in learning and memory
as well as the degeneration of neurons especially in the hippocampus formation are
hallmarks of the pathogenesis of AD. Within the last decades much effort has been
expended into understanding the pathogenesis of AD. However, little is known about
the physiological role of APP within the central nervous system (CNS). Allocating APP
to the proteome of the highly dynamic presynaptic active zone (PAZ) identified APP as
a novel player within this neuronal communication and signaling network. The analysis
of the hippocampal PAZ proteome derived from APP-mutant mice demonstrates that
APP is tightly embedded in the underlying protein network. Strikingly, APP deletion
accounts for major dysregulation within the PAZ proteome network. Ca2+-homeostasis,
neurotransmitter release and mitochondrial function are affected and resemble the
outcome during the pathogenesis of AD. The observed changes in protein abundance
that occur in the absence of APP as well as in AD suggest that APP is a structural and
functional regulator within the hippocampal PAZ proteome. Within this review article, we
intend to introduce APP as an important player within the hippocampal PAZ proteome
and to outline the impact of APP deletion on individual PAZ proteome subcommunities.
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INTRODUCTION
The development of a neuronal circuit requires precise coordination of billions of neurons, with
up to 100,000 synaptic connections each, forming a stable but plastic network and persisting
over the lifespan of an organism (Turrigiano, 2008, 2012). The key word deciphering this
phenomenon is ‘‘homeostasis’’ and was introduced by Walter Cannon in the early 1930’s
(Cannon, 1932). Within the neuronal network numerous homeostatic mechanisms ensure
physiological activity in a spatio-temporal manner on various groups of synapses (Turrigiano,
2008; Yu and Goda, 2009). Maintenance of synaptic homeostasis demands on a coordinated
proteomic response at both—pre- and postsynaptic sites (Schanzenbächer et al., 2016).
Abbreviations: AD, Alzheimer’s disease; APLP1/2, amyloid precursor like proteins1 and 2; APP, amyloid precursor
protein; CA, cornu ammonis; HD, Huntington’s disease; PAZ, presynaptic active zone; PD, Parkinson’s disease;
SNAP25, synaptosomal associated protein 25; SV2, synaptic vesicle protein 2; VAMP2, vesicle associated membrane
protein2/synaptobrevin2.
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Consecutive steps of processing the arrival of an action
potential into a chemical signal by recruiting a subset
of individual proteins that fuse synaptic vesicles with the
presynaptic plasma membrane, release of their neurotransmitter
into the synaptic cleft, which further react with their
specific receptor at the postsynapse (Figure 1), demands
on a rather stringent progression. Key players within this
network comprise prominent candidates like synaptic vesicle
protein 2 (SV2), synaptotagmin-1, synaptosomal associated
protein 25 (SNAP25), syntaxin and vesicle associated membrane
protein2/synaptobrevin2 (VAMP2; Südhof and Rizo, 2011;
Südhof, 2012; Laßek et al., 2015). The unique set of proteins
regulating, mediating and controlling proper presynaptic
physiology was recently complemented by a yet unappreciated
companion—the amyloid precursor protein (APP).
APP—A BRIEF PROFILE
The APP belongs to an evolutionary conserved gene family
with specific expression pattern in C. elegans, Drosophila
and mammals (reviewed in Coulson et al., 2000; Jacobsen
and Iverfeldt, 2009). Discovered during the 1980s as
precursor protein of A-beta (Aβ)—the main constituent of
senile plaques—much effort has been made to understand
the pathophysiology of Alzheimer’s disease (AD) and the
physiological function of APP (Glenner and Wong, 1984; Kang
et al., 1987). The progression of AD is characterized by a massive
loss of synapses especially within the hippocampus. Extracellular
senile plaques and intracellular neurofibrillary tangles induce
and promote successive degeneration of neurons manifested
by severe impairments in learning and memory and behavioral
changes (Grundke-Iqbal et al., 1986; Supnet and Bezprozvanny,
2010). Enzymatic processing of APP is initiated by either
β-secretase/γ-secretase (amyloidogenic pathway) cleavage, or
α-secretase/γ- secretase (non-amyloidogenic pathway). The
proteolytic processing of amyloid precursor like proteins 1 and 2
(APLP1 and APLP2) is comparable to that of APP, however,
only the amyloidogenic pathway can induce the formation of
Aβ-peptides (Eggert et al., 2004). Until now, little is known
about the shift in enzymatic processing of the APP leading to
FIGURE 1 | Amyloid precursor protein (APP) allocated to the presynaptic active zone (PAZ). (A) Schematic surface illustration (left) and cartoon (right)
representing the domain organization of APP (modeling structures are created by PyMOL Molecular Graphics system based on X-ray data from protein data base,
PDB; 11.2010). Heparin-binding domain/ growth factor-like domain (HBD/GFLD, green), disulfide bridges (yellow), copper-binding domain (CuBD, orange),
zinc-binding domain (ZnBD, bright orange), acidic domain (DE, firebrick), Kunitz protease inhibitor domain (blue), collagene binding domain (violet), A-beta (Aβ)
sequence (cyan), secretase cleavage site (pale cyan), transmembrane segment (dark teal), YENPTY sequence (magenta), NPXY sequence (purple), FE65 adaptor
protein (white), non-modeled render sequences (ruby). (B) Subdivision of domains (D1-D9) in APP695 (expressed in neurons) and APP770 (KPI highlighted in blue,
acidic domain highlighted in blue). (C) Schematic cartoon of a chemical synapse highlighting APP at the PAZ.
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the accumulation of Aβ-peptides and the formation of oligomers
and fibrils. Since senile plaques consist mainly of Aβ-fibrils, it
was of great interest how these structures are organized (Lu et al.,
2013). The analysis of these fibrils derived from AD patients
revealed an individual molecular structure. These variations
were suggested to correlate with the severity of impairments
in the individual pathogenesis of AD in patients (Lu et al.,
2013).
APP is a type 1 transmembrane protein with a large
N-terminal domain, a single transmembrane region and a
short C-terminal domain (Figure 1). The N-terminal domain
is subdivided into an E1 domain comprising a heparin-
binding/growth factor-like domain (HBD/GFLD), a copper and
zinc-binding domain (CuBD/ZnBD) followed by an acidic
region (DE), optionally a KPI-domain (not present in the
neuronal specific isoformAPP695), and an E2 domain consisting
of a second HBD (HBD2) a collagen-binding region and
N-glycosylation binding sites (Jacobsen and Iverfeldt, 2009;
Kaden et al., 2012). The APP intracellular domain (AICD)
contains the highly conserved YENPTY motif involved in the
internalization of APP and phosphorylated or dephosphorylated
tyrosine mediated binding of adaptor proteins like FE65
(Figure 1), Dab1 and X11a (munc-18 interacting protein, Mint;
Jacobsen and Iverfeldt, 2009). All APP family members reveal a
high structural overlap except the Aβ domain that is only present
in mammalian APP.
APP AT THE SYNAPSE
Multiple isoforms were described for mammalian APP (e.g.,
695aa, 770aa), but only APP695aa is expressed in neurons.
Within neurons, APP was discussed as bona fide SV (Groemer
et al., 2011) and constituent of the presynaptic plasma
membrane (Marquez-Sterling et al., 1997; Lyckman et al.,
1998). In addition, APP was described as a constituent of
endocytosed synaptic vesicles, but being sorted away from
bona fide synaptic vesicles (Marquez-Sterling et al., 1997). On
the contrary, Groemer et al. (2011) reported a small copy
number of APP to synaptic vesicles as a result of endosomal
synaptic vesicle recycling processes. However, they emphasized
that the majority of APP was immunodetected in fractions
containing the plasma membrane, and only a small amount
was present in purified synaptic vesicle fractions (Groemer
et al., 2011). In our studies, we clearly demonstrated that APP
and its family members are constituents of the presynaptic
plasma membrane and that APP is virtually absent from
synaptic vesicles (Laßek et al., 2013). Within the presynaptic
nerve terminal, a small section characterized by an assembly
of electron dense material, is responsible for Ca2+-triggered
exocytosis of synaptic vesicles. This section is called presynaptic
active zone (PAZ; Gray, 1963; Südhof, 2012). The composition
of the PAZ proteome identified the release site as dynamic
focal hot spot, providing the prerequisite for structural and
functional changes also in the adult nerve terminal. Neuronal
communication and signal transduction depends not only on
the concerted action of individual proteins within the PAZ
but also on proper energy supply (Boveris and Navarro,
2008). Besides the glycolytic chain associated with synaptic
vesicles (reviewed in Burré and Volknandt, 2007), mitochondria
are the main source for the production of ATP at the
presynaptic terminal. Therefore, mitochondria are essential
in maintaining presynaptic homeostasis and phosphorylation
reactions and are highly involved in synaptic plasticity (reviewed
in Mattson et al., 2008). The allocation of APP to the
proteome of this highly dynamic substructure of the presynapse,
identified APP as yet unknown player within the neuronal
communication and signaling network (Laßek et al., 2013,
2016).
To address the question which physiological function APP
is executing in the central nervous system (CNS), a variety
of genetically designed mouse models has been generated
(Heber et al., 2000; Ring et al., 2007; Hick et al., 2015).
It turned out that loss of APP causes an age-dependent
phenotype with no severe physiological impairments in younger
mice but impairments in learning and memory in the elderly
(Phinney et al., 1999; Ring et al., 2007). At postsynaptic
sites, reduced dendritic length and branching accompanied
by a total spine density reduction was characteristic for old
APP-KO mice and indicates a physiological role of APP
in maintaining spine density (Tyan et al., 2012). This was
further supported by Weyer et al. (2014) demonstrating
a specific role of APP in sustaining spine structure and
density. Classification of spine structure can be morphologically
addressed revealing stubby, thin and mushroom spines. In
APP-KO cornu ammonis 1 (CA1) neurons this spine subtype
distribution is altered by a significant decrease in mushroom
spines (Weyer et al., 2014). Interestingly, substantial changes
of the proteomic composition of neurotransmitter release
sites are already detectable in younger mice (Laßek et al.,
2014, 2016). Since APP plays an essential role during the
development of the neuronal circuit (Lazarov and Demars,
2012), it was suggested that the APLP2 compensates for
the loss of APP (Weyer et al., 2011; Laßek et al., 2016).
Screening immunopurified PAZs derived from individual total
mouse brain revealed prominent players to be affected by
APP deletion. Candidates like SV2A, synaptotagmin-1 and
synaptophysin turned out to be differentially regulated. It is
worth mentioning, that the opposite effect was observed for
deletion of either APLP1 or APLP2 (Laßek et al., 2014).
Moreover, deletion of the family members did not result in
any morphological alterations in CNS or overall impairments in
learning and memory (Heber et al., 2000; Weyer et al., 2011).
Memory formation requires a variety of network oscillations
that are regularly synchronized between hippocampal CA1 and
CA3 region (Korte et al., 2012). As inhibitory interneurons play
an essential role in this coordinated action of synchronization,
their oscillations can affect a large population of pyramidal
neurons, inhibiting specific input pathways and guarantee for
a high background-to-noise ratio (Mann and Paulsen, 2007).
Accompanied with the observed shift in the excitatory-inhibitory
ratio in APP-KO mice, it was suggested that GABAA receptor-
mediated inhibition is altered in aged APP-KO mice and
that these changes contribute to the reduction in LTP in
aged APP-KO mice. This assumption was further sustained by
Frontiers in Molecular Neuroscience | www.frontiersin.org 3 February 2017 | Volume 10 | Article 43
Weingarten et al. APP at the PAZ
LTP-rescue experiments employing pharmacological blockade
of GABAA receptors (Fitzjohn et al., 2000; Korte et al.,
2012). Synaptic plasticity requires persistent changes within
the entire network. Thereby, the strength of a neuronal
connection is individually adjusted (up or down) dependent on
homeostatic synaptic scaling (Turrigiano, 2012; Davis, 2013).
Homeostasis implies the capability to restore individual baseline
functions upon continued input. This is achieved by controlling
and modulating the expression and trafficking of specific
proteins and protein complexes. Initially, synaptic scaling
was described as bidirectional modulation of neurotransmitter
receptor abundance at individual synapses. In this context, it
was suggested that this effect stabilizes neuronal excitability while
sustaining learning-related information (Turrigiano, 2008, 2012;
Davis, 2013). At presynaptic sites, homeostasis encompasses
the fast, long-lasting and accurate modulation of synaptic
vesicle fusion (Davis, 2013). Alteration at protein level as
response to homeostatic scaling in hippocampal neurons was
recently analyzed by Schanzenbächer et al. (2016). They
uncovered the necessity of new protein synthesis upon up-
or down scaling induced by pharmacological treatment. More
than 300 proteins (e.g., neurotransmitter receptors, scaffolding
and signaling proteins) were affected by this stimulation.
Strikingly, genes affected by the stimulation, encode for proteins
critically involved in neurological diseases like AD, Parkinson’s
disease (PD) or schizophrenia. Proteins identified and regulated
by homeostatic scaling in this approach provide a starting
point to examine how their dysregulation might contributes
to a variety of neuronal disorders (Schanzenbächer et al.,
2016).
APP AND THE HIPPOCAMPUS
APP is functionally integrated into the hippocampal PAZ
proteome and fits into the evolutionary conserved active zone
protein complex, comprising prominent constituents like ELKS,
CASK bassoon, RIM and Munc18 (Südhof, 2012; Laßek et al.,
2016). Embedding APP into the entire PAZ proteome unraveled
APP as a context-sensitive regulator with impact on synaptic
vesicle cycle, cytoskeletal organization and Ca2+-homeostasis.
Deletion of APP significantly affects those proteins serving
as mediator (e.g., α-synuclein) within the PAZ but not their
central players (e.g., SNARE-machinery). It was obvious, that
loss of APP accounts for individual rearrangements of the
entire network structure with no current effect on presynaptic
functionality (Laßek et al., 2016). Interestingly, these massive
alterations in protein abundance within the PAZ proteome
did not account for impairments in learning and memory
pointing to a yet unknown compensatory mechanism in
young APP-KO mice (Ring et al., 2007). The most important
guarantors for sufficient energy metabolism, calcium- and
redox homeostasis are mitochondria (Yin et al., 2014; Grimm
et al., 2016). They support the intracellular energy demand
by producing ATP, affect redox-sensitive kinases via second
messengers H2O2 and NO and regulate the NAD+/NADH
homeostasis, involved in maintenance of mitochondrial energy
statues (Yin et al., 2014). A recent proteome study on young
and old APP-KOmice revealed drastic changes in mitochondrial
protein abundance at hippocampal neurotransmitter release
sites. These results indicated that old APP-KO mice display a
dysregulation in their bioenergetics metabolism accompanied
by hyperphosphorylation of CaMKII (Laßek et al., 2017).
It is tempting to speculate that during the induction of
LTP CaMKII becomes over-activated, which has a negative
impact on synaptic plasticity, and prevents proper learning
and memory consolidation. Recently, over-activation of CaMKII
was described in hippocampal neurons following synaptic
stimulation and increased intracellular Ca2+-levels. As a kind of
protective mechanism, CaMKII is able to form clusters (spherical
clusters, identical in size and shape) preventing excessive
protein phosphorylation, independent of the autocatalytic center,
due to an imbalance in Ca2+-homeostasis (Dosemeci et al.,
2007). Therefore, cognitive impairments in old APP-KO mice
might be associated with an imbalance in mitochondrial
function and phosphorylation-activity of the serine/threonine-
specific kinases CaMKII as observed during the progression
of AD (Grimm et al., 2016). Thermodynamic imbalance and
compensatory mechanisms acting in impaired neurons, will
further induce a competition for energy substrates and finally
shift formerly healthy neurons into affected ones (Demetrius
et al., 2015).
The expression pattern of APP in the hippocampus and
especially at PAZs has been further analyzed in detail by
Rodrigues et al. (2014), demonstrating that APP is most
abundant on glutamatergic neurotransmitter release sites as
compared to GABAergic ones. Their findings further revealed
that less than half of hippocampal synapses were immunopositive
for APP (Rodrigues et al., 2014). Strikingly, deletion of APP
accounts for an increase in activity of GABAergic synapses.
This dysregulation in balance between inhibitory and excitatory
neurons was induced by a diminished endocytosis of VDCC in
GABAergic hippocampal neurons (Yang et al., 2009). In this
context it is worth mentioning the idea of graded molecular
profiles of hippocampal neurons (here CA1 neurons) stated
by Cembrowski et al. (2016). The hippocampal formation has
been attributed with regional-specific functions. Whereas the
dorsal hippocampus is known to be associated with cognitive
functions (like memory and spatial navigation) the ventral
region is basically associated with behavior (like stress and
emotion; Fanselow and Dong, 2010; Strange et al., 2014).
Illustrating the gene expression profile along the dorsal-ventral-
axis of CA1 neurons revealed unique profiles of decay. These
findings make it rather interesting to figure out how those
CA1 neurons perform their region-specific functions. In line
with these findings similar considerations were made for the
diversity of presynaptic performance. Atwood and Karunanithi
(2002) described various models of functional differentiation
of presynaptic neurons. (1) Different amounts of strength-
regulating presynaptic proteins or a variable combination of
more than one presynaptic protein can be induced or attracted
by a postsynaptic neuron. (2) Neuronal activity or specific input
to presynaptic neurons can induce a differential occurrence
of presynaptic proteins in different neurons (Atwood and
Karunanithi, 2002). However, if the molecular profile and
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physiology of those neurons is different, what about the profile of
individually expressed proteins? The abundance of several PAZ
proteins differs considerably between brain regions, presumably
reflecting region-specific functional adaptions. This can be
of vital importance to understand the impact of therapeutic
drugs (e.g., prevalence or therapy of AD) on their targets and
to elucidate their subsequent effects on the PAZ proteome.
The identification of individual PAZ protein components is
a prerequisite for further functional investigations and also
provides a solid basis for evaluating their interaction. Therefore,
differences in the PAZ proteome reflect specific adaptions to
regional neuronal circuitries and the functional and structural
dynamics of their corresponding release sites (Weingarten
et al., 2015). Salient findings by Schwenk et al. (2014) are
in accordance with this dynamic and functional diversity
of proteomes. They demonstrated that a large multiprotein
complex provides an individual assembly of its core-subunits
and a regional specific architecture over space and time
(Schwenk et al., 2014). This perspective is indispensable for
those proteins sharing a differential expression pattern (like
APP)—not only in specific brain regions but also in neurons
and individual synapses, respectively. A current study by
Counts et al. (2014) went a step further, performing molecular
profiling of CA1 neurons derived from patients with mild
cognitive impairment (MCI) and AD—MCI, is a prodromal
stage of AD. It is widely accepted that early pathological events
triggering the outcome of AD are associated with CA1 neurons.
Compared to control groups (NCI, no cognitive impairments),
expression of genes involved in proper synaptic function in
CA1 neurons, is severely dysregulation in MCI, whereas no
further changes were observed in AD. Interestingly, APP,
APLP1 and APLP2 transcripts were not altered at any stage
in CA1 neurons. Molecular profiling of CA1 neurons revealed
that early changes in synaptic elements provide susceptibility to
cognitive decline in aged patients. These findings point to an
early onset of synaptic failure that becomes manifested in the
dysregulation of the hippocampal neuronal circuit (Counts et al.,
2014).
CONCLUDING REMARKS
Our proteomic profiling of PAZs derived from total mouse brain
revealed a summary of all alterations due to loss of APP. Going
a step further, looking only at the hippocampus, the picture
of presynaptic changes was impressively refined. Therefore,
the next step should include proteomic studies addressing
the molecular profiling of individual neurons within the
hippocampus. Combining our approaches with new technologies
will provide novel insights into the biological function of
APP within the CNS. Moreover, interdisciplinary approaches
and sustained exchanges of information can facilitate new
perspectives within the challenging APP research field.
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